15th – 16th October 2019

Kerry Hotel Pudong, Shanghai


Kunihiko Suzuki

Kunihiko Suzuki

Vice President, Vice Chairman, MEDINET Co., Ltd, FIRM

Kunihiko SUZUKI (Vice President, Member of the Board at MEDINET) started his career at MEDINET in biotech industry in 2006, after 20 year-experiences in commercial/investment banking industry in both Japan and Europe. 

MEDINET specializes in the immuno-cell therapy for cancer patients and also act as the contract development & manufacturing organization for both private sector and public sector such as hospitals, clinics, academia, which conduct their activities under “Pharmaceuticals and Medical Devices Act ” (PMD Act) and “The Act on the Safety of Regenerative Medicine” (RM Safety Act).

SUZUKI also take position as a Vice Chairman at FIRM (Forum for Innovative Regenerative Medicine) in June 2014, after 3 years serving as a member of Steering Committee and a preceding year as a member of Establishment Committee of FIRM.  FIRM consists of more than 250 private companies, several non-profit organizations and limited individual members, which have the mission to promote Regenerative Medicine and to contribute to Japanese economic growth as an industrial advocacy group.